SciSparc Grants an Exclusive License for the Sales of CannAm

TEL AVIV, Israel, June 07, 2023 -- SciSparc Ltd. , a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system,... | June 7, 2023

Related Keywords

Israel , Canada , , Health Products Directorate , Company Or Scisparc , Nasdaq , Health Canada , Exchange Commission , Scisparc Ltd , Scisparc Nutraceuticals Inc , Scisparc Nutraceuticals , Non Prescription Health Products Directorate , Sparc Nutraceutical , License Agreement , Scisparc Nutraceuticals Cannamide , Tourette Syndrome , Looking Statements , Private Securities Litigation Reform Act , Scisparc Nutraceutical , Annual Report , Scisparc Stock Exchange , News , Information , Press Release , El , Pune , 023 , Scisparc , Specialty , Harmaceutical , Company , Ocusing , N , The , Development , F , Therapies , O , Treat , Disorders , Central , Ervous Sprc Il0010951403 ,